Aurora Spine Corporation (ASAPF) Income Statement Analysis

See more : S.J.S. Enterprises Limited (SJS.BO) Income Statement Analysis – Financial Results

Complete financial analysis of Aurora Spine Corporation (ASAPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aurora Spine Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.

You may be interested

Aurora Spine Corporation (ASAPF)

Industry: Medical - Devices

Sector: Healthcare

Website: https://www.aurora-spine.com

About Aurora Spine Corporation

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	14.52M	14.88M	10.54M	8.65M	11.15M	8.68M	5.99M	6.76M	4.90M	2.59M	206.99K
Cost of Revenue	6.31M	7.07M	5.71M	5.18M	7.61M	4.09M	3.43M	3.37M	2.21M	1.14M	82.80K
Gross Profit	8.21M	7.81M	4.83M	3.47M	3.55M	4.59M	2.56M	3.38M	2.69M	1.45M	124.19K
Gross Profit Ratio	56.55%	52.49%	45.84%	40.12%	31.81%	52.90%	42.73%	50.08%	54.91%	56.04%	60.00%
Research & Development	1.11M	1.16M	941.30K	286.25K	207.55K	36.30K	21.06K	40.41K	78.12K	280.69K	158.19K
General & Administrative	6.82M	6.08M	4.99M	3.65M	3.89M	3.64M	3.70M	4.11M	4.71M	7.30M	1.14M
Selling & Marketing	722.29K	1.05M	799.93K	106.01K	138.92K	47.14K	31.86K	91.43K	287.68K	1.00M	140.28K
SG&A	7.54M	7.12M	5.79M	3.76M	4.03M	3.68M	3.74M	4.20M	5.00M	8.30M	1.28M
Other Expenses	0.00	868.59K	648.69K	589.54K	386.65K	780.56K	984.11K	0.00	0.00	0.00	0.00
Operating Expenses	8.66M	9.15M	7.38M	4.63M	4.63M	4.50M	4.74M	5.00M	5.81M	8.96M	1.45M
Cost & Expenses	14.97M	16.22M	13.10M	9.81M	12.23M	8.59M	8.17M	8.37M	8.02M	10.10M	1.45M
Interest Income	0.00	0.00	0.00	4.63K	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	185.17K	163.60K	157.70K	92.35K	174.01K	147.59K	144.65K	60.93K	26.93K	0.00	0.00
Depreciation & Amortization	1.05M	834.17K	642.98K	620.68K	395.64K	740.76K	855.88K	752.84K	750.81K	385.82K	3.80K
EBITDA	-446.20K	-450.68K	-1.54M	-686.23K	-709.74K	816.09K	-1.35M	-869.19K	-2.00M	-7.15M	-3.40M
EBITDA Ratio	-3.07%	-2.74%	-18.03%	-6.64%	-6.21%	10.04%	-22.62%	-12.67%	-52.56%	-274.90%	-696.43%
Operating Income	-446.20K	-1.34M	-2.55M	-1.16M	-1.08M	91.44K	-2.18M	-1.68M	-3.12M	-7.51M	-1.45M
Operating Income Ratio	-3.07%	-9.03%	-24.19%	-13.46%	-9.68%	1.05%	-36.42%	-24.85%	-63.70%	-289.79%	-698.27%
Total Other Income/Expenses	-1.23M	-158.06K	191.04K	931.31K	-174.79K	-159.64K	-59.30K	0.00	205.32K	0.00	0.00
Income Before Tax	-1.68M	-1.50M	-2.36M	-232.09K	-1.25M	-68.20K	-2.24M	-1.68M	-2.92M	-7.51M	-1.45M
Income Before Tax Ratio	-11.57%	-10.09%	-22.37%	-2.68%	-11.25%	-0.79%	-37.41%	-24.85%	-59.51%	-289.79%	-698.27%
Income Tax Expense	0.00	62.29K	159.10K	87.71K	174.01K	12.05K	-85.35K	60.93K	-205.32K	0.00	0.00
Net Income	-1.68M	-1.56M	-2.52M	-319.80K	-1.43M	-80.25K	-2.16M	-1.68M	-2.92M	-7.51M	-1.45M
Net Income Ratio	-11.57%	-10.51%	-23.88%	-3.70%	-12.81%	-0.92%	-35.98%	-24.85%	-59.51%	-289.79%	-698.27%
EPS	-0.02	-0.02	-0.04	-0.01	-0.03	0.00	-0.06	-0.05	-0.11	-0.35	-0.22
EPS Diluted	-0.02	-0.02	-0.04	-0.01	-0.03	0.00	-0.06	-0.05	-0.11	-0.35	-0.22
Weighted Avg Shares Out	70.67M	66.80M	58.71M	54.63M	46.46M	42.15M	35.18M	32.22M	25.95M	21.62M	6.58M
Weighted Avg Shares Out (Dil)	70.67M	66.80M	58.71M	54.63M	46.46M	42.15M	35.18M	32.22M	25.95M	21.62M	6.58M

Aurora Spine Corporation to Participate in Alliance Global Partners Virtual MedTech Summer Conference

July 28, 2021globenewswire.com

CARLSBAD, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its management team will be...

Aurora Spine Corporation to Attend Third Annual American Society of Pain & Neuroscience Conference

July 21, 2021globenewswire.com

- As part of conference, Aurora to host a hands-on Training Lab -

Aurora Spine Corporation to Present at the Lytham Partners Summer 2021 Investor Conference

June 8, 2021globenewswire.com

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will participate in...